Navigation Links
Biotech Pioneer William J. Rutter to Deliver Keynote at 2008 RAPS Horizons Conference
Date:2/18/2008

ROCKVILLE, Md., Feb. 18 /PRNewswire-USNewswire/ --- Biotech pioneer William J. Rutter, PhD, will deliver a keynote speech at the 2008 RAPS Horizons Conference & Exhibition in San Francisco next month, the Regulatory Affairs Professionals Society (RAPS) has announced.

Rutter, Chairman and CEO of Synergenics LLC and co-founder of biotech industry leader Chiron, will stimulate fresh and relevant perspectives on the regulatory implications of advances in biological and medical science that are driving new products and individually-oriented treatment strategies.

Among the issues Rutter will address:

-- Individualized cancer drug therapy

-- Cancer vaccines

-- Genetic-based therapy

-- Immunological control of disease via administered antibodies or vaccines

-- Stem cell therapy

"Dr. Rutter's unique experience with the rapidly shifting nature of science and healthcare products will provide us with crucial insight into evolving treatment regimens/protocols and regulatory strategies," said RAPS Executive Director Sherry L. Keramidas, PhD, CAE.

Under Rutter's leadership, Chiron placed a major emphasis on detection, prevention and treatment of infectious diseases. With Merck, Chiron developed a Hepatitis B vaccine, based on the Hepatitis B pseudoparticles from yeast. Rutter's commitment to funding research on important diseases led to two of Chiron's most enduring achievements: the cloning and first sequencing of the HIV genome in 1984, and the discovery, sequencing and cloning of the hepatitis C virus in 1987.

Keramidas emphasized the commonalities of innovation across various healthcare product lines, including devices, drugs and biotechnology, and the need to utilize the most recent science to discover new treatments and to bring these treatments to consumers safely and more efficiently.

Additionally, Keramidas said that regulatory professionals are increasingly working in more than one of these product areas, often focusing on a wide array of products launched in a number of regions worldwide.

"Our members are working across product lines and across the globe. Dr. Rutter's breakthroughs and scientific leadership are instructional for all regulatory professionals," said Keramidas.

The 2008 RAPS Horizons Conference & Exhibition, scheduled 26-28 March at the Fairmont San Francisco, is expected to draw hundreds of scientists, regulatory leaders and professionals from the biotechnology, pharmaceutical and medical device industries, government, academia, research and clinical organizations.

For more information or to register for Horizons, visit the RAPS website, http://www.raps.org/horizons.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) guides and supports individuals--from industry, government, academia, research and clinical organizations--to bring life-saving and life-enhancing products to the global marketplace quickly and safely.

Founded in 1976 and operating outside the political arena, RAPS provides a neutral forum on emerging science and global regulatory challenges, offering personal and professional resources to help regulatory professionals continuously improve and work smarter, faster and in compliance with regulatory models.

RAPS established the regulatory profession worldwide and brings knowledge and progress to it. By identifying s, developing professional certification, and providing educational and networking opportunities, RAPS supports professionals throughout the healthcare product lifecycle. http://www.raps.org


'/>"/>
SOURCE Regulatory Affairs Professionals Society (RAPS)
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
3. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
4. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
5. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
6. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
7. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio
8. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
9. Shareholder Class Action Filed Against GPC Biotech AG by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
10. Favrille CEO to Present at NewsMakers in the Biotech Industry Investment Conference
11. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly ... technologies, services and solutions to the healthcare market. The company's primary focus is ... manufacturing, sales and marketing strategies that are necessary to help companies efficiently bring ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
Breaking Biology News(10 mins):